Symbol="FNCH"
AssetType="Common Stock"
Name="Finch Therapeutics Group Inc"
Description="Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutic company, is developing a new class of orally administered biologic drugs in the United States. The company is headquartered in Somerville, Massachusetts."
CIK="1733257"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="200 INNER BELT ROAD, SOMERVILLE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="14844700"
EBITDA="-83095000"
PERatio="None"
PEGRatio="None"
BookValue="20.57"
DividendPerShare="0"
DividendYield="0"
EPS="-110.34"
RevenuePerShareTTM="0.385"
ProfitMargin="0"
OperatingMarginTTM="-144.36"
ReturnOnAssetsTTM="-0.391"
ReturnOnEquityTTM="-1.448"
RevenueTTM="614000"
GrossProfitTTM="-57032000"
DilutedEPSTTM="-110.34"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.698"
AnalystTargetPrice="150"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="23.38"
PriceToBookRatio="0.362"
EVToRevenue="6.54"
EVToEBITDA="-0.132"
Beta="0.152"
num_52WeekHigh="87.27"
num_52WeekLow="7.36"
num_50DayMovingAverage="9.7"
num_200DayMovingAverage="20.7"
SharesOutstanding="1604800"
DividendDate="None"
ExDividendDate="None"
symbol="FNCH"
open="8.54"
high="9.30"
low="8.54"
price="9.25"
volume="13069.00"
latest_trading_day="2023-07-07"
previous_close="9.04"
change="0.21"
change_percent="2.3230%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="84"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="16"
Volume_recent_avg="228087"
Change_recent_avg="0.05"
Delta_recent_avg="0.23"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="1.59"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="16"
Aroon_momentum_negative="84"
image_negative_thumbnail_id_1="1109"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0142.jpeg"
image_negative_thumbnail_id_2="1090"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0123.jpeg"
image_neutral_thumbnail_id_1="541"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_neutral_thumbnail_id_2="598"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_positive_thumbnail_id_1="662"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0046.jpeg"
image_positive_thumbnail_id_2="1004"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0166.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
